A Switch Therapy for Community-acquired Pneumonia: A Randomized Controlled Trial.

Trial Profile

A Switch Therapy for Community-acquired Pneumonia: A Randomized Controlled Trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Oct 2011

At a glance

  • Drugs Garenoxacin (Primary) ; Sulbactam/ampicillin
  • Indications Bacterial infections; Community-acquired pneumonia
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Oct 2011 Results presented at the 77th Annual Meeting of the American College of Chest Physicians: Chest 2011.
    • 23 Jul 2011 Actual end date (Mar 2011) as reported by University Hospital Medical Information Network - Japan.
    • 23 Jul 2011 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top